Segunda línea en cáncer de pulmón de células no - page 14

Treatment-related select Aes in nivolumab-treated patients in pooled CheckMate

017/057; 2 years minimum follow-up

Mercury No: ONCES15NP00692-01

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,4,5,6,7,8,9,10,11,12,13 15,16,17,18,19,20,21,22,23,24,...41